References Agarwal A, Chandran A, Raza F, Ungureanu IM, Hilcenko C, Stott K, Bright NA, Morone N, Warren AJ, Lautenschlger J (2024) VAMP2 regulates phase separation of -synuclein
Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request
Reduced need for antacid medications, improved nighttime symptoms, and decreased frequency of episodes characterize this phase
Sunscreen Protection: Protects skin from harmful UV rays to prevent further sun damage
If you experience any adverse effects or have concerns, seek advice from a healthcare provider
For further guidance on aseptic preparation and beyond-use dating of injectable products in UK practice, refer to SPS (Specialist Pharmacy Service) resources and MHRA guidance on the manufacture of IMPs